ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,000 | +150.0% | 15,154 | +195.1% | 0.00% | – |
| Q1 2017 | $2,000 | -33.3% | 5,135 | -7.1% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 5,525 | -6.8% | 0.00% | – |
| Q3 2016 | $3,000 | -40.0% | 5,925 | +3.5% | 0.00% | – |
| Q2 2016 | $5,000 | +150.0% | 5,725 | +97.4% | 0.00% | – |
| Q1 2016 | $2,000 | -50.0% | 2,900 | 0.0% | 0.00% | – |
| Q4 2015 | $4,000 | -85.2% | 2,900 | -76.4% | 0.00% | – |
| Q3 2015 | $27,000 | -60.9% | 12,270 | -58.7% | 0.00% | – |
| Q2 2015 | $69,000 | +7.8% | 29,740 | -0.3% | 0.00% | – |
| Q1 2015 | $64,000 | +326.7% | 29,840 | +335.6% | 0.00% | – |
| Q4 2014 | $15,000 | -28.6% | 6,850 | -8.0% | 0.00% | – |
| Q3 2014 | $21,000 | -34.4% | 7,448 | -12.9% | 0.00% | – |
| Q2 2014 | $32,000 | -95.1% | 8,550 | -84.5% | 0.00% | – |
| Q1 2014 | $649,000 | +19.3% | 55,225 | -15.5% | 0.00% | – |
| Q4 2013 | $544,000 | -23.7% | 65,335 | -15.1% | 0.00% | -100.0% |
| Q3 2013 | $713,000 | +4.5% | 76,961 | +10.6% | 0.00% | 0.0% |
| Q2 2013 | $682,000 | – | 69,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu KCG Holdings LLC | 86,824 | $31,000 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 46,100 | $17,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,405 | $0 | 0.00% |
| CITIGROUP INC | 9,751 | $4,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 17,281 | $6,000 | 0.00% |
| MORGAN STANLEY | 4,250 | $2,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 48,944 | $18,000 | 0.00% |
| BlackRock Inc. | 927,688 | $334,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 6,600 | $2,000 | 0.00% |
| Bank of New York Mellon Corp | 62,846 | $22,000 | 0.00% |